Pharmacology in the Catheterization Laboratory

Pharmacology in the Catheterization Laboratory

Editor(s): Ron Waksman, Andrew E. Ajani

Published Online: 30 OCT 2009

Print ISBN: 9781405157049

Online ISBN: 9781444306347

DOI: 10.1002/9781444306347

About this Book

Cardiologists today prescribe medications with complex mechanisms of action, pharmacokinetics, indications, contraindications and drug-frug interactions; many of which were not available when today's practitioners were in training. This book was written to meet the growing demand for complete, detailed and accurate cardiac pharmacology information.

This in-depth examination of the specific types of pharmacological agents used in the cardiac catheterization lab - as well as those routinely prescribed for cardiac patients - evaluates drugs with respect to their:

  • Cellular and physiological actions
  • Prescribed usage
  • Dosages
  • Adverse reactions
  • Cautions
  • Common routes of administration

Opening chapters discuss anticoagulation therapies and antiplatelet therapies. later chapters cover percutaneous coronary intervention and its possible complications, post-procedure pharmacotherapy, and anticoagulation anomalies.

Drawing on the expertise of contributors from around the world, Pharmacology in the Catheterization Laboratory is the perfect blend of evidence and experience.

Table of contents

    1. You have free access to this content
  1. Part I: Elective PCI Anticoagulation Therapy/Thrombin Inhibitors

  2. Part II: Antiplatelet Therapy

    1. Chapter 8

      Cangrelor (pages 53–58)

      Julie H. Oestreich and Steven R. Steinhubl

  3. Part III: Acute Coronary Syndrome STEMI/NSTEMI

    1. Chapter 19

      High-Dose Tirofiban (pages 154–157)

      Bart Dawson, Debabrata Mukherjee and David J. Moliterno

  4. Part IV: Elective PCI Miscellaneous

  5. Part V: High-Risk PCI

  6. Part VI: PCI Complications

  7. Part VII: Postprocedural Pharmacotherapy

  8. Part VIII: Anticoagulation Anomalies

    1. Chapter 35

      Heparin-Induced Thrombocytopenia (pages 261–269)

      Ignacio Cruz-Gonzalez, Maria Sanchez-Ledesma and Ik-Kyung Jang

  9. Part IX: Systemic Pharmacotherapy for in-Stent Restenosis

    1. You have free access to this content
    1. You have free access to this content